申请人:UNIV CALIFORNIA
公开号:WO2022261204A1
公开(公告)日:2022-12-15
Disclosed are compounds of formula (I): formula (I) and pharmaceutically acceptable salts thereof. The compounds of the invention are BDII- selective inhibitors of BET proteins, and have therapeutic potential for treating cancer, acute kidney disease, and viral infections, among other diseases.
本发明涉及以下公式(I)的化合物:公式(I)及其药学上可接受的盐。本发明的化合物是BET蛋白的BDII选择性抑制剂,具有治疗癌症、急性肾脏疾病、病毒感染等疾病的治疗潜力。